Suggestions
Meryl Zausner
Member of Board of Directors at Seres Therapeutics and Goldfinch Bio
Meryl Zausner is a retired C-suite executive with over 35 years of management experience in the pharmaceutical and consumer products industries.1 She served as Board of Directors-Audit Committee Chair and member of the Governance Committee at Goldfinch Bio from February 2021 to January 2023.1 Her career highlights include:
Professional Experience
- Executive Vice President (EVP) and Chief Financial Officer (CFO) at Novartis Corporation2
- VP & CFO Global Oncology at Novartis from September 2000 to June 20081
- Various roles at Novartis Pharmaceuticals and OTC from 1988 to 20001
- Financial Controller at Colgate-Palmolive from 1981 to 19881
Education and Certifications
- B.S. in Accounting and Economics from University at Albany, SUNY1
- Certified Public Accountant (New York State, 1981)1
- Certified Coach (International Coaching Federation)1
Awards and Recognition
- Healthcare Businesswomen's Association Woman of the Year (2007)1
- Gilda's Club Red Door Honoree (2009)1
- Named one of the 100 Most Inspiring People by PharmaVoice Magazine (2014)1
Meryl Zausner is known for her role in creating the blueprint for the successful Novartis Oncology Business Unit and launching the first Novartis shared services organization.1 She is recognized as a developer of diverse talent and continues to serve on public and nonprofit boards.1